Abstract
This audit study examines availability of and wait times for Medicaid enrollee appointments with psychiatric prescribing clinicians across 4 of the most populous US cities.
Medicaid enrollees face a disproportionate burden of severe mental illness yet have lower access to treatment.1 Psychiatrists are less likely than other physicians to accept insurance, especially Medicaid.2 This disparity is exacerbated by inaccurate health plan provider directories: a previous claims-based study of 2018 Medicaid managed care directories revealed that in some plans, over 90% of listed mental health care prescribers did not actively participate in the Medicaid program, but claims-based studies cannot assess wait times or enrollees’ direct experiences with accessing care.3,4,5
We conducted a “secret shopper” audit study to examine availability of and wait times for adult appointments with psychiatric prescribing clinicians across 4 of the most populous US cities.
Methods
We selected at random 80 psychiatric prescribing clinicians (psychiatrists, nurse practitioners, and physician assistants) listed as accepting new patients from the provider directories for the Medicaid managed care plans with the highest enrollment in New York City, Los Angeles, Chicago, and Phoenix, the 4 largest cities in states that have expanded Medicaid eligibility under the Patient Protection and Affordable Care Act. Using a standardized protocol and calling script, 5 researchers called sampled clinicians during normal business hours between May 12, 2023, and July 6, 2023, as Medicaid enrollees seeking the soonest available appointment. When an appointment could not be provided with the sampled clinician, callers requested consultation with an alternate clinician at the same practice (eAppendix in Supplement 1).
We examined appointment availability, wait times, and reasons an appointment could not be made with the sampled clinician. We made comparisons between cities for appointment availability with the χ2 test with Bonferroni correction. We compared wait times with a 1-way analysis of variance test. Analyses were performed with Stata version 16 (StataCorp). We defined significance as 2-sided P < .05. The study was approved by the institutional review board at the Biomedical Research Alliance of New York, which provided a waiver of informed consent because the research involved minimal risk and could not be carried out without a waiver, and a waiver would not adversely affect individuals being studied.
Results
Across the 320 clinician offices called, 87 (27.2%) had appointments available, including 57 (17.8%) with the sampled clinician and 30 (9.4%) with an alternate clinician at the same practice. The proportion of calls resulting in an appointment with any clinician was 36.3% in New York City, 30.0% in Phoenix, 27.5% in Chicago, and 15.0% in Los Angeles. The 2 cities with significantly different appointment availabilities were New York and Los Angeles (P = .002). Median wait times were 11 days (IQR, 6-20 days) in Phoenix, 23 days (IQR, 9-35 days) in Chicago, 28 days (IQR, 11-84 days) in New York, and 64 days (IQR, 24-126 days) in Los Angeles (Figure 1). The cities with significantly different wait times were Phoenix and Los Angeles (P = .001), Phoenix and New York City (P = .03), and Chicago and Los Angeles (P = .049).
Figure 1. Wait Times for Appointments With Psychiatric Clinicians Across 4 of the Largest US Cities.
“Any clinician” indicates wait times for appointments across both sampled clinicians and alternate clinicians when alternates were offered. Boxes indicate IQR and central horizontal line indicates median. The lower whisker represents the lower adjacent value, which is equal to the 25th percentile minus 1.5 times the IQR. The upper whisker represents the upper adjacent value, which is equal to the 75th percentile plus 1.5 times the IQR. Dots indicate outlier observations. For 17 of the 87 available appointments, wait times could not be obtained without a more extensive registration or onboarding process.
Among the 263 sampled clinicians with whom appointments could not be made, 15.2% had a listed number that was incorrect or out of service and 35.0% did not answer the phone on either of 2 attempts (Figure 2).
Figure 2. Reasons Appointments Not Available With Sampled Psychiatric Clinicians Across 4 of the Largest US Cities.
Each bar shows the distribution by city of reasons an appointment could not be secured with the sampled clinician. Appointments were not available for 66 clinicians in Chicago, 73 clinicians in Los Angeles, 59 clinicians in New York City, and 65 clinicians in Phoenix.
Discussion
In the largest Medicaid managed care plans across 4 of the largest US cities, only 17.8% of clinicians listed as in-network for Medicaid were reachable, accepted Medicaid, and could provide a new patient appointment. When access did exist, it often was not timely, with wait times up to 6 months.5
A limitation is the lack of a comparison group of enrollees with commercial health insurance, although previous studies have established that Medicaid enrollees have lower access to care than those with other forms of insurance. Calls were placed only to practices in urban areas and the cited diagnosis for requesting an appointment when prompted was depression; results may not generalize to rural areas or patients seeking treatment for other conditions.
A recent regulation from the Centers for Medicare & Medicaid Services requires states to conduct independent secret shopper surveys to directly assess network adequacy in Medicaid managed care.6 This study highlights the importance of greater enforcement of network adequacy standards through tools such as audit studies to safeguard access to care in the Medicaid program.
Section Editors: Kristin Walter, MD, and Jody W. Zylke, MD, Deputy Editors; Karen Lasser, MD, MPH, Senior Editor.
eAppendix. Methods
Data Sharing Statement
References
- 1.Saunders H, Rudowitz R. Demographics and health insurance coverage of nonelderly adults with mental illness and substance use disorders in 2020. KFF. Published June 6, 2022. Accessed February 12, 2023. https://www.kff.org/mental-health/issue-brief/demographics-and-health-insurance-coverage-of-nonelderly-adults-with-mental-illness-and-substance-use-disorders-in-2020
- 2.Bishop TF, Press MJ, Keyhani S, Pincus HA. Acceptance of insurance by psychiatrists and the implications for access to mental health care. JAMA Psychiatry. 2014;71(2):176-181. doi: 10.1001/jamapsychiatry.2013.2862 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Goldman HH. How phantom networks and other barriers impede progress on mental health insurance reform. Health Aff (Millwood). 2022;41(7):1023-1025. doi: 10.1377/hlthaff.2022.00541 [DOI] [PubMed] [Google Scholar]
- 4.Zhu JM, Charlesworth CJ, Polsky D, McConnell KJ. Phantom networks: discrepancies between reported and realized mental health care access in Oregon Medicaid. Health Aff (Millwood). 2022;41(7):1013-1022. doi: 10.1377/hlthaff.2022.00052 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ludomirsky AB, Schpero WL, Wallace J, et al. In Medicaid managed care networks, care is highly concentrated among a small percentage of physicians. Health Aff (Millwood). 2022;41(5):760-768. doi: 10.1377/hlthaff.2021.01747 [DOI] [PubMed] [Google Scholar]
- 6.Medicaid program: Medicaid and Children’s Health Insurance Program (CHIP) managed care access, finance, and quality. Fed Regist. 2024;88:28092. To be codified at 42 CFR §430, §438, and §457. Accessed June 6, 2024. https://www.federalregister.gov/documents/2024/05/10/2024-08085/medicaid-program-medicaid-and-childrens-health-insurance-program-chip-managed-care-access-finance
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
eAppendix. Methods
Data Sharing Statement


